Diagonal Bio Return On Equity vs. Shares Outstanding
| DIABIO Stock | 0.02 0 8.51% |
For Diagonal Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Diagonal Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Diagonal Bio AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Diagonal Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Diagonal Bio AB over time as well as its relative position and ranking within its peers.
Diagonal |
Diagonal Bio AB Shares Outstanding vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Diagonal Bio's current stock value. Our valuation model uses many indicators to compare Diagonal Bio value to that of its competitors to determine the firm's financial worth. Diagonal Bio AB is rated # 2 in return on equity category among its peers. It is rated # 4 in shares outstanding category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Diagonal Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Diagonal Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Diagonal Shares Outstanding vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Diagonal Bio |
| = | -0.52 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Diagonal Bio |
| = | 34.77 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Diagonal Shares Outstanding Comparison
Diagonal Bio is currently under evaluation in shares outstanding category among its peers.
Diagonal Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Diagonal Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Diagonal Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Diagonal Bio's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Diagonal Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Use Investing Themes to Complement your Diagonal Bio position
In addition to having Diagonal Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Diagonal Stock
To fully project Diagonal Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Diagonal Bio AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Diagonal Bio's income statement, its balance sheet, and the statement of cash flows.